Today: 7 February 2026
Subscribe
Browse Category

Health News News 10 December 2025 - 5 January 2026

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

New York, January 5, 2026, 14:21 EST — Regular session Shares of Viking Therapeutics (VKTX) slid 9.9% to $31.93 in afternoon trading on Monday as obesity-drug stocks reacted to Novo Nordisk’s U.S. launch of a Wegovy weight-loss pill. Novo’s U.S.-listed shares rose 5.1%, while Eli Lilly fell 3.9% and the SPDR S&P Biotech ETF dropped 2.2%. The move highlights how sensitive obesity-drug developers remain to pricing signals from the market leaders. Viking has no approved products, so changes in expected pricing can hit the stock as hard as trial data. Direct-to-consumer discounts are also changing how investors think about margins
5 January 2026
······
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

New York, Jan 5, 2026, 13:31 EST — Regular session Arrowhead Pharmaceuticals shares were down about 6.9% on Monday after the company said Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock fell $4.68 to $63.11 after swinging between $60.75 and $70.87. MarketScreener The clearance gives Arrowhead another regulated market for its first commercial product, as investors shift attention from the science to execution. It also keeps the spotlight on how quickly the company can convert approvals into reimbursed prescriptions. The selloff underscored how hard it can be for single-stock catalysts to cut through sector tape.
5 January 2026
·····
Tesco issues urgent “do not eat” recall for three pate lines after date-label error

Tesco issues urgent “do not eat” recall for three pate lines after date-label error

LONDON, January 4, 2026, 13:02 ET Britain’s Tesco has recalled three 170-gram own-brand pate products after they were labelled with an incorrect use-by date, prompting a warning over a possible microbiological risk, the UK’s Food Standards Agency said on Jan. 3. The recall covers Tesco Coarse Farmhouse Pate, Coarse Ardennes Pate and Smooth Chicken Liver Pate with a use-by date of 05 January 2026. Food Standards Agency Use-by dates are safety deadlines for foods that spoil quickly, and the watchdog warns people should not eat food after that date even if it looks and smells normal. Mislabelled dates can leave
4 January 2026
·
Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

Bupa renews ParalympicsGB partnership and seals Nuffield Health deal as robotic knee surgery hits 1,000 mark

NEW YORK, January 1, 2026, 06:51 ET Bupa UK on Wednesday renewed its role as Official Healthcare Partner of ParalympicsGB and agreed a new three-year contract between Bupa UK Insurance and Nuffield Health, the company said. The Nuffield agreement adds direct appointment booking and wider access to diagnostics for Bupa customers. (Source) The moves matter because speed to diagnosis is a selling point in private healthcare, where delays between referral, scans and treatment can drive customer frustration. Bupa is also tying its brand to elite sport at a time when sponsors are under pressure to show measurable health outcomes. For
1 January 2026
··
Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

NEW YORK, December 31, 2025, 19:19 ET — After-hours Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05 to treat agitation linked to Alzheimer’s disease and granted it Priority Review. The agency set an April 30, 2026 target action date, and CEO Herriot Tabuteau said “up to 76% of people with Alzheimer’s disease experience agitation.” GlobeNewswire The decision matters because Priority Review shortens the FDA’s review timeline, pulling a key regulatory catalyst forward for investors who have been
1 January 2026
····
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup of the latest news, forecasts, and analysis available as of 23.12.2025, and what investors are watching next. What is Structure Therapeutics, and why does GPCR trade like a headline detector? Structure Therapeutics is a clinical-stage biopharmaceutical company developing oral small-molecule
23 December 2025
·····
FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

On December 22, 2025, Novo Nordisk won one of the most consequential regulatory decisions in modern obesity medicine: U.S. FDA approval of a once‑daily “Wegovy pill” (oral semaglutide 25 mg) for chronic weight management—marking the first oral GLP‑1 authorized in the U.S. specifically for weight loss. Novo Nordisk+1 For Novo Nordisk, the milestone is more than a product expansion. It’s a high‑stakes move to defend its GLP‑1 franchise, widen access beyond injections, and reassert momentum after a volatile year in which investors questioned its growth trajectory and competitive positioning. Reuters+1 What the FDA approved on December 22, 2025 The Wegovy
23 December 2025
··
So Delicious Dairy Free Ice Cream Recall: Danone Pulls Salted Caramel Cluster Pints Over Possible “Small Stones” (Dec. 17, 2025)

So Delicious Dairy Free Ice Cream Recall: Danone Pulls Salted Caramel Cluster Pints Over Possible “Small Stones” (Dec. 17, 2025)

December 17, 2025 — If you keep dairy-free frozen treats stocked for the holidays, it’s worth taking a quick look in your freezer. Danone U.S. has issued a voluntary nationwide recall for specific pints of So Delicious Dairy Free Salted Caramel Cluster after the company warned the product may contain foreign materials — including small stones and other hard objects — in the cashew pieces mixed into the dessert. U.S. Food and Drug Administration+1 The recall, which was posted by the U.S. Food and Drug Administration (FDA) as a company announcement, applies to a single So Delicious flavor and pint
18 December 2025
·
California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

California Vega Farms Egg Recall: 63 Sick, 13 Hospitalized in Salmonella Outbreak—How to Identify Affected Eggs

SACRAMENTO, Calif. (Dec. 15, 2025) — A Salmonella Enteritidis outbreak in California has been linked to recalled Vega Farms in-shell brown eggs, with state health officials reporting 63 illnesses and 13 hospitalizations (and no deaths) tied to the outbreak strain as of Dec. 5, according to the California Department of Public Health (CDPH). California Department of Public Health The recall centers on eggs distributed in Northern California—primarily the Sacramento and Davis areas—and sold not only through retail outlets but also supplied to restaurants and farmers markets, officials said. California Department of Public Health+1 What’s driving the warning: testing, inspection, and
16 December 2025
Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

Vega Farms Egg Recall Update: California Links Salmonella Outbreak to Dixon Farm Eggs; 63 Sick, 13 Hospitalized

SACRAMENTO, Calif. (Dec. 13, 2025) — California health officials are urging residents and businesses across parts of Northern California to stop eating, selling, or serving certain Vega Farms in-shell eggs after the products were linked to a Salmonella Enteritidis outbreak that has already sickened dozens of people. California Department of Public Health+1 The California Department of Public Health (CDPH) says that 63 California residents were reported ill as of Dec. 5, 2025, including 13 hospitalizations, with no deaths reported. The eggs were voluntarily recalled by Vega Farms, Inc. on Dec. 5, 2025, and the state has since released details to
13 December 2025
McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

McCain Pizza Pockets Recall Australia 2025: Cheese & Bacon 400g Pulled from Woolworths, Coles and IGA After Plastic and Metal Contamination Warning

Australians are being urged to check their freezers after McCain Foods (Aust) Pty Ltd issued a nationwide recall for McCain Cheese & Bacon Pizza Pockets (400g) following reports of foreign material in the product. The recall, published on Friday, 12 December 2025, covers items sold through major supermarkets and online deliveries across the country. Food Standards Australia New Zealand+1 The warning is straightforward: do not eat the affected pizza pockets. Food safety authorities say food products containing plastic and/or metal can cause illness or injury if consumed, and the product should be returned to the place of purchase for a
12 December 2025
Johnson & Johnson (JNJ) Stock After Hours on December 9, 2025: New Cancer Breakthrough, Dividend Payout and What to Watch Before the December 10 Open

Johnson & Johnson (JNJ) Stock After Hours on December 9, 2025: New Cancer Breakthrough, Dividend Payout and What to Watch Before the December 10 Open

Key Takeaways Below, we’ll walk through what happened to Johnson & Johnson stock after the bell on December 9 and what investors should watch before the U.S. market opens on Wednesday, December 10, 2025. 1. How Johnson & Johnson Stock Traded on December 9, 2025 Regular session: hot open, cold close On Tuesday, December 9, 2025, Johnson & Johnson shares: Volume came in at roughly 5–7 million shares, around or slightly below JNJ’s recent average daily volume of ~6.8 million shares, suggesting a normal‑liquidity, mild risk‑off session rather than a panic move. StockInvest+1 Early in the day, JNJ actually helped
10 December 2025
·····
1 2 3 4

Stock Market Today

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

7 February 2026
Rio Tinto’s U.S. shares closed up 2.5% at $93.37 Friday after the company ruled out a merger with Glencore, triggering a six-month “no-bid” lockout under UK takeover rules. Both companies cited disagreements over valuation. Attention now turns to Rio’s Feb. 19 results and iron ore prices, which fell below $100 a tonne amid weak Chinese demand.
iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Go toTop